4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0000313143-14-000138
President & CEO sold 4,765 shares at $36.72 ($174,979)
- President & CEO acquired 4,765 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CONCANNON BRIAN · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-12-01 | Exercise or conversion : show line 1 in the form | +4,765 | $27.28 | $129,965 | 151,805 | D |
| 2014-12-01 | Sale : show line 2 in the form | −4,765 | $36.72 | $174,979 | 147,040 | D |
| Open-market sales · 4,765 sh · avg $36.72 · $174,979 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2014-12-01 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) | −4,765 | $36.72 | $174,979 | $27.28 | 2015-10-22 | 4,765 | 47,646 | D |
Loading xslF345X03/edgardoc.xml…